Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 1.1B | 1.1B | 987M | 906M |
| Cost of revenue | 398M | 378M | 337M | 334M |
| Gross profit | 697M | 723M | 650M | 572M |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 13M | 23M | 44M | 8M |
| Other operating expenses | 186M | 231M | 211M | 182M |
| Operating income | 375M | 354M | 261M | 262M |
| Non operating interest income | ||||
| Income | 110M | 97M | 98M | 110M |
| Expense | 8M | 8M | 8M | 8M |
| Other income expense | — | — | — | — |
| Pretax income | 1.5B | 1.5B | 2.0B | 1.5B |
| Tax provision | 88M | 156M | 198M | 155M |
| Net income | 1.4B | 1.3B | 1.8B | 1.3B |
| Basic EPS | — | 242 | — | — |
| Diluted EPS | — | 242 | — | — |
| Basic average shares | — | 5.4M | — | — |
| Diluted average shares | — | 5.4M | — | — |
| EBITDA | 1.5B | 1.5B | 2.0B | 1.6B |
| Net income from continuing op. | 1.5B | 1.5B | 2.0B | 1.5B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | 0 | 0 | 0 | 0 |